Related Experiment Video
Updated: Aug 16, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Pediatric pulmonology 2021 year in review: Asthma
Nicole Stephenson1, Ceila E Loughlin1
1Department of Pediatrics, School of Medicine, The University of North Carolina, Chapel Hill, North Carolina, USA.
Insights
In 2021, the COVID-19 pandemic significantly impacted pediatric asthma, affecting exacerbations and healthcare use. Research advanced asthma diagnostics, treatments, and understanding of social determinants and costs.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Public Health
Background:
- Asthma is a leading chronic childhood illness in the U.S., impacting millions.
- The COVID-19 pandemic (SARS-CoV-2) significantly altered asthma exacerbations and healthcare utilization in 2021.
- The year 2021 saw critical advancements in asthma research.
Purpose of the Study:
- To review key publications and developments in pediatric asthma from 2021.
- To contextualize findings within major pulmonary topics and relevant literature.
- To highlight progress in diagnostics, treatment, and understanding of asthma's broader impact.
Main Methods:
- Review of selected literature published in 2021 concerning pediatric asthma.
- Synthesis of findings across major pulmonary journals and related disciplines.
- Analysis of research trends in asthma management and care.
Main Results:
- Significant impact of SARS-CoV-2 on asthma exacerbations and healthcare utilization was observed.
- Improvements were noted in asthma diagnostic testing and monitoring protocols.
- Advances were made in the treatment of severe asthma exacerbations.
- Increased focus on social determinants of health and evaluation of medical costs in asthma care.
Conclusions:
- 2021 research provided crucial insights into managing pediatric asthma amidst a pandemic.
- Progress in diagnostics and treatment offers improved patient outcomes.
- Addressing social determinants and costs is vital for comprehensive asthma management.
Abstract:
Asthma is the most common chronic disease in children, affecting an estimated 6.1 million children in the United States. SARS-CoV2 had a significant impact on asthma exacerbations and healthcare utilization of patients with asthma in 2021. Additionally, studies in 2021 influenced the field of asthma with improvements in diagnostic testing and monitoring, treatment of severe exacerbations, social determinants of health, and evaluation of medical costs. This article is part of our 2021 "Year in Review" series, in which we summarize publications in major pulmonary topics, in the context of selected literature from other journals relevant to our discipline.
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-I: Introduction
Asthma-IV: Nursing Management
First, in...
Asthma-III: Symptoms and Complications
Classification of Asthma

